Next Article in Journal
Viroimmunotherapy of Thoracic Cancers
Next Article in Special Issue
Development of Phosphorothioate DNA and DNA Thioaptamers
Previous Article in Journal
Cellular and Molecular Preconditions for Retinal Pigment Epithelium (RPE) Natural Reprogramming during Retinal Regeneration in Urodela
Article Menu
Issue 1 (March) cover image

Export Article

Open AccessReview
Biomedicines 2017, 5(1), 1;

Aptamer Technology: Adjunct Therapy for Malaria

Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Health Campus, Kubang Kerian, 16150 Kelantan, Malaysia
Author to whom correspondence should be addressed.
Academic Editor: Vittorio de Franciscis
Received: 7 November 2016 / Revised: 8 December 2016 / Accepted: 16 December 2016 / Published: 4 January 2017
(This article belongs to the Special Issue Engineering Aptamers for Biomedical Applications)
Full-Text   |   PDF [1233 KB, uploaded 4 January 2017]   |  


Malaria is a life-threatening parasitic infection occurring in the endemic areas, primarily in children under the age of five, pregnant women, and patients with human immunodeficiency virus and acquired immunodeficiency syndrome (HIV)/(AIDS) as well as non-immune individuals. The cytoadherence of infected erythrocytes (IEs) to the host endothelial surface receptor is a known factor that contributes to the increased prevalence of severe malaria cases due to the accumulation of IEs, mainly in the brain and other vital organs. Therefore, further study is needed to discover a new potential anti-adhesive drug to treat severe malaria thus reducing its mortality rate. In this review, we discuss how the aptamer technology could be applied in the development of a new adjunct therapy for current malaria treatment. View Full-Text
Keywords: Plasmodium falciparum; malaria; cytoadherence; adjunct therapy; aptamer Plasmodium falciparum; malaria; cytoadherence; adjunct therapy; aptamer

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Nik Kamarudin, N.A.A.; Mohammed, N.A.; Mustaffa, K.M.F. Aptamer Technology: Adjunct Therapy for Malaria. Biomedicines 2017, 5, 1.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Biomedicines EISSN 2227-9059 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top